Nath Bio-Genes Q4 FY26 Earnings Conference Call Transcript

Nath Bio-Genes held its Q4 FY26 earnings conference call on May 5, 2026, discussing audited financial results for the quarter and year ended March 31, 2026.
FY26 revenue grew 19% YoY to INR 4,316 million with PAT of INR 384 million, driven by strong performance in cotton (22% volume growth), paddy (37% value growth), and maize (78% value growth).
The company achieved a milestone with its Uzbekistan JV contributing INR 15 crores to consolidated revenue and provided conservative FY27 growth guidance of 15-20% for top line.
Management addressed El Nino impacts, portfolio diversification strategy, working capital management, and international expansion plans targeting 10-15% of revenue from overseas operations in the medium term.